PAP Smear (LBC/JAR)

A PAP Smear (LBC/JAR) is a screening test used to detect abnormal cervical cells, including precancerous changes and cervical cancer. Liquid-Based Cytology (LBC) and Jar methods improve sample collection and analysis, increasing accuracy in detecting cellular abnormalities caused by the human papillomavirus (HPV) or other infections. Regular screening helps in early detection and prevention of cervical cancer.

This test is essential for women’s health, especially for those with a history of HPV infection, irregular bleeding, or risk factors for cervical cancer. It involves collecting a sample of cervical cells, which are then analyzed for any abnormalities. LBC technology provides clearer results by reducing debris and blood contamination.

No fasting is required, but it is recommended to avoid intercourse, douching, or using vaginal medications 24-48 hours before the test for optimal results. The best time for the test is between menstrual cycles to ensure accurate detection of abnormal cells.

PAP Smears are crucial for early detection, allowing timely treatment and prevention of cervical cancer. Women aged 21 and above, especially those who are sexually active, should undergo regular screening every 3-5 years based on medical advice. Consulting a doctor for interpretation and follow-up in case of abnormal results is important for maintaining reproductive health.